Equivalent mobilization and collection of granulocytes for transfusion after administration of glycosylated G-CSF (3 microg/kg) plus dexamethasone versus glycosylated G-CSF (12 microg/kg) alone.

Transfusion

Volumn 42, Issue 7, 2002, Pages 928-934

  Heuft, H G ^a   Goudeva, L ^a   Sel, S ^a   Blasczyk, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; FEMALE; GRANULOCYTE; HUMAN; LEUKAPHERESIS; MALE; METHODOLOGY; MIDDLE AGED; NEUTROPHIL; PHARMACOKINETICS; PROSPECTIVE STUDY; STEM CELL MOBILIZATION;

ADULT; BLOOD COMPONENT TRANSFUSION; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; NEUTROPHILS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; THERAPEUTIC EQUIVALENCY;

EID: 0036653510     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00133.x     Document Type: Article

References (0)